Dubuque Bank & Trust Company Decreased Stake in Celgene Corp (CELG) as Shares Declined

April 17, 2018 - By Benjamin Allen

Celgene Corporation (NASDAQ:CELG) Corporate LogoDuring Q4 2017 the big money sentiment decreased to 0.83. That’s change of 0.34, from 2017Q3’s 1.17. 156 investors sold all, 478 reduced holdings as CELG ratio worsened. 411 rose stakes while 118 funds acquired stakes. Funds hold 561.38 million shares thus 7.06% less from 2017Q3’s 603.99 million shares. Bristol John W Ny owns 582,179 shs. The Pennsylvania-based Mycio Wealth Partners Ltd Co has invested 0.53% in Celgene Corporation (NASDAQ:CELG). Bridges Invest Mgmt reported 1.68% of its capital in Celgene Corporation (NASDAQ:CELG). Kamunting Street Management Lp owns 11,000 shs. Btr Capital Incorporated holds 2,065 shs or 0.04% of its capital. Sonata Group Inc accumulated 0.31% or 4,133 shs. First Foundation Advisors accumulated 0.14% or 25,127 shs. Retirement Sys Of Alabama reported 643,943 shs. Thomas White Int, a Illinois-based fund reported 7,805 shs. Cannell Peter B stated it has 1.58M shs. North Amer Corp has 0.16% invested in Celgene Corporation (NASDAQ:CELG). American Financial owns 25,000 shs. Canada Pension Plan Inv Board has 0.42% invested in Celgene Corporation (NASDAQ:CELG) for 2.15M shs. Indiana & stated it has 16,003 shs. Sigma Counselors owns 28,224 shs.

CELG registered $3.58 million net activity with 1 buying transaction and 3 selling transactions since February 8, 2018. On Monday, March 12 9,250 shs were sold by LOUGHLIN JAMES J, worth $851,093. KAPLAN GILLA sold $1.77M worth of stock or 18,500 shs. Alles Mark J bought $299,594 worth of stock.

In Celgene Corp (CELG) was reduced the holdings held by Dubuque Bank & Trust Company. The decrease is 97.7% according to 2017Q4 Securities and Exchange filling. The company’s stock declined 19.30% with the market as Dubuque Bank & Trust Company sold 48,338 shares. At the end of 2017Q4, the 1,136 shares of the major pharmaceuticals company held by the institutional investor were priced at $119,000, down from 49,474 at the end of the previous reported quarter. For a total of 1.77M shares it increased its holding in Heartland Financial Usa Inc (NASDAQ:HTLF) by 192,188 shares in the quarter, and has risen its stake in .

Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on April, 26. They expect $1.78 earnings per share, up 16.34 % or $0.25 from last year’s $1.53 per share. CELG’s profit will be $1.34B for 12.70 P/E if the $1.78 EPS becomes a reality. After $1.87 actual earnings per share reported by Celgene Corporation for the previous quarter, Wall Street now forecasts -4.81 % negative EPS growth.

Celgene Corporation (NASDAQ:CELG) Ratings Coverage

Total analysts of 28 have positions in Celgene (NASDAQ:CELG) as follows: 15 rated it a “Buy”, 1 with “Sell” and 12 with “Hold”. The positive are 54%. Since October 20, 2017 according to StockzIntelligence Inc Celgene has 59 analyst reports. On Thursday, October 26 the firm has “Buy” rating given by Cowen & Co. In Monday, October 30 report Credit Suisse maintained it with “Buy” rating and $128.0 target. On Friday, October 27 the firm earned “Outperform” rating by BMO Capital Markets. The stock rating was downgraded by Bernstein to “Market Perform” on Wednesday, December 27. The stock rating was maintained by Cowen & Co with “Buy” on Friday, October 20. The stock rating was maintained by Citigroup with “Neutral” on Friday, October 27. On Thursday, January 25 the firm earned “Buy” rating by Guggenheim. In Wednesday, December 13 report Leerink Swann maintained it with “Buy” rating and $120.0 target. On Friday, October 20 the rating was maintained by Stifel Nicolaus with “Buy”. On Wednesday, March 21 the firm has “Overweight” rating by JP Morgan given.

Celgene Corporation (NASDAQ:CELG) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.